These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16242626)

  • 1. Progressive supranuclear palsy: a systematic review.
    Rampello L; Buttà V; Raffaele R; Vecchio I; Battaglia G; Cormaci G; Alvano A
    Neurobiol Dis; 2005 Nov; 20(2):179-86. PubMed ID: 16242626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and genetic aspects of progressive supranuclear palsy.
    Litvan I; Hutton M
    J Geriatr Psychiatry Neurol; 1998; 11(2):107-14. PubMed ID: 9877531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on epidemiological aspects of progressive supranuclear palsy.
    Litvan I
    Mov Disord; 2003 Sep; 18 Suppl 6():S43-50. PubMed ID: 14502655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. J. Clifford Richardson and 50 years of progressive supranuclear palsy.
    Williams DR; Lees AJ; Wherrett JR; Steele JC
    Neurology; 2008 Feb; 70(7):566-73. PubMed ID: 18268249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau and saitohin gene expression pattern in progressive supranuclear palsy.
    Ezquerra M; Gaig C; Ascaso C; Muñoz E; Tolosa E
    Brain Res; 2007 May; 1145():168-76. PubMed ID: 17320831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into progressive supranuclear palsy.
    Albers DS; Augood SJ
    Trends Neurosci; 2001 Jun; 24(6):347-53. PubMed ID: 11356507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ApoE and tau on age of onset of progressive supranuclear palsy and multiple system atrophy.
    Morris HR; Schrag A; Nath U; Burn D; Quinn NP; Daniel S; Wood NW; Lees AJ
    Neurosci Lett; 2001 Oct; 312(2):118-20. PubMed ID: 11595348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?
    Silveira-Moriyama L; González AM; O'Sullivan SS; Williams DR; Massey L; Parkkinen L; Ahmed Z; de Silva R; Chacón JR; Revesz T; Lees AJ; Holton JL
    Neurosci Lett; 2009 Dec; 467(3):208-11. PubMed ID: 19835934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
    Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
    Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology of variants of progressive supranuclear palsy.
    Dickson DW; Ahmed Z; Algom AA; Tsuboi Y; Josephs KA
    Curr Opin Neurol; 2010 Aug; 23(4):394-400. PubMed ID: 20610990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
    Ali F; Josephs K
    Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive supranuclear palsy: clinical and genetic aspects.
    Pastor P; Tolosa E
    Curr Opin Neurol; 2002 Aug; 15(4):429-37. PubMed ID: 12151839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
    Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
    Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges.
    Williams DR; Lees AJ
    Lancet Neurol; 2009 Mar; 8(3):270-9. PubMed ID: 19233037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy.
    Litvan I; Baker M; Hutton M
    Neurology; 2001 Jul; 57(1):138-40. PubMed ID: 11445645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in progressive supranuclear palsy and frontotemporal dementia.
    Chiu WZ; Kaat LD; Seelaar H; Rosso SM; Boon AJ; Kamphorst W; van Swieten JC
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):441-5. PubMed ID: 20360166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.